MedPath

Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver Cirrhosis

Phase 3
Recruiting
Conditions
Liver Cirrhosis
Registration Number
NCT06478602
Lead Sponsor
Cristian Ichim
Brief Summary

The study aims to investigate the beneficial effects of fecal transplantation in patients diagnosed with liver cirrhosis (regardless of etiology).

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Diagnosis of liver cirrhosis according to current protocols.
  • Conscious and cooperative adult patients.
Exclusion Criteria
  • Patients with hemodynamic and/or respiratory instability.
  • Patients with contraindications for colonoscopy or fecal transplantation.
  • Patients with acute or chronic infections with HIV, Tuberculosis, MDR Enterobacteria, CMV, parasites, fungi.
  • Associated oncological pathology.
  • Patients with other causes of severe immunodeficiencies.
  • Lack of compliance with the conditions imposed by the research project.
  • Patients who do not sign the informed consent.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Implications of fecal microbiota transplantation in modulating the effects of liver cirrhosis.Up to 3 months

The transfer of microbiota could potentially influence hepatic fibrosis via the gut-liver axis, as well as other complications caused by cirrhosis such as encephalopathy, ascites etc.

Implications of fecal microbiota transplantation in modulating the condition of other organs.Up to 3 months

The transfer of microbiota could potentially modulate the function of other major organs in the body.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

County Clinical Emergency Hospital of Sibiu

🇷🇴

Sibiu, Romania

County Clinical Emergency Hospital of Sibiu
🇷🇴Sibiu, Romania
Cristian Ichim, Resident Doctor
Contact
0040771643848
cristian.ichim@ulbsibiu.ro
Victoria Birlutiu, Prof. Dr.
Sub Investigator
Adrian Boicean, Prof. Dr.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.